Novartis

BEOVU

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / BEOVU – J0179

Manufacturer:

Novartis

Name:

BEOVU

HCPCS Code Descriptor:

Injection, brolucizumab-dbll, 1 mg

Category:

J Code

HCPCS:

J0179

NDC(s):

00078-0827-60

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intraocular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

BEOVU is an Opthalmic drug manufactured by Novartis and administered via the Intraocular route of administration. The J Code: J0179 is aligned to the drug BEOVU.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/20

HCPCS Effective Date:

1/1/20

HCPCS Short Description:

Inj, brolucizumab-dbll, 1 mg

Billing and Coding Guide:

https://p.widencdn.net/cgoqsr/BVU-1391588-BEOVU-J-Code-Billing--Coding-Guide---Electronic_PI-Update-6.20

Patient Assistance:

https://www.mygooddays.org/

https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment

BEOVU - J0179